✦ LIBER ✦

Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges

✍ Scribed by Marsh, Kevin; Xu, Peng; Orfanos, Panagiotis; Benedict, Agnes; Desai, Kamal; Griebsch, Ingolf

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Model-Based Cost-Effectiveness Analyses

✍ Stephanie R. Earnshaw; Michele Wilson; Josephine Mauskopf; Ashish V. Joshi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

PCHI4: MEDICAL TREATMENT FOR CHRONIC MYE

✍ MT Groot; GJ Ossenkoppele; MHH Kramer; G van den Boom; PC Huijgens; CA Uyl-de Gr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Cost effectiveness of imatinib compared

✍ K. Dalziel; A. Round; R. Garside; K. Stein 📂 Article 📅 2005 🏛 Springer International Publishing AG 🌐 English ⚖ 171 KB

Cost–utility analysis of imatinib mesila

✍ Gordois, A; Scuffham, P; Warren, E; Ward, S 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

PCN95 A MARKOV MODEL TO ESTIMATE THE COS

✍ NJ Brereton; AJ Batty; CF Foy; AL McCormick 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PMH11 A COST-EFFECTIVENESS ANALYSIS MODE

✍ J Mould; I Contreras-Hernandez; W Verduzco; J Gardufio-Espinosa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB